Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Ohio State University Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT00143065

First received: August 31, 2005

Last updated: October 20, 2011

Last verified: October 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2009
Primary Completion Date:	February 2007 (Final data collection date for primary outcome measure)